784 related articles for article (PubMed ID: 18199536)
21. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
[TBL] [Abstract][Full Text] [Related]
23. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
Palumbo T; Faucz FR; Azevedo M; Xekouki P; Iliopoulos D; Stratakis CA
Oncogene; 2013 Mar; 32(13):1651-9. PubMed ID: 22614013
[TBL] [Abstract][Full Text] [Related]
24. MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.
Zhao H; Yu X; Ding Y; Zhao J; Wang G; Wu X; Jiang J; Peng C; Guo GZ; Cui S
Oncotarget; 2016 Aug; 7(33):53254-53268. PubMed ID: 27449101
[TBL] [Abstract][Full Text] [Related]
25. STAT3 regulated
Jin P; Liu Y; Wang R
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30061175
[TBL] [Abstract][Full Text] [Related]
26. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
27. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
30. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.
Li J; Hu K; Gong G; Zhu D; Wang Y; Liu H; Wu X
Sci Rep; 2017 Feb; 7():41330. PubMed ID: 28145479
[TBL] [Abstract][Full Text] [Related]
32. PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression.
Wu H; Wang K; Liu W; Hao Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):141-6. PubMed ID: 24434152
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.
Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y
Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627
[TBL] [Abstract][Full Text] [Related]
34. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
Liu S; Fang Y; Shen H; Xu W; Li H
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):756-62. PubMed ID: 23824073
[TBL] [Abstract][Full Text] [Related]
35. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance.
Li B; Chen H; Wu N; Zhang WJ; Shang LX
Int J Gynecol Cancer; 2014 Oct; 24(8):1381-8. PubMed ID: 25248111
[TBL] [Abstract][Full Text] [Related]
37. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.
van Jaarsveld MT; van Kuijk PF; Boersma AW; Helleman J; van IJcken WF; Mathijssen RH; Pothof J; Berns EM; Verweij J; Wiemer EA
Mol Cancer; 2015 Nov; 14():196. PubMed ID: 26576679
[TBL] [Abstract][Full Text] [Related]
38. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
Li J; Jiang K; Zhao F
Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
[TBL] [Abstract][Full Text] [Related]
39. Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment.
Li L; Li L; Hu L; Li T; Xie D; Liu X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476500
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
